Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-2824

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-2824). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Pdp (68071 2824 9)

Pdp (68071 2824 9)
Packaging label for Atorvastatin Calcium 20 mg film-coated tablets by NuCare Pharmaceuticals, Inc. The label indicates a quantity of 90 tablets, prescription use only. It includes manufacturer information for Sun Pharmaceutical Industries Limited, Mohali, India, and identifies the tablet as elliptical, white, debossed with 'RX 828'. The label also features barcodes, NDC 68071-2824-9, and storage instructions.*
FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
A line graph comparing cumulative incidence percentages over time in years for Atorvastatin versus placebo groups. The graph shows two curves with Atorvastatin having a lower cumulative incidence than placebo. A hazard ratio of 0.64 (95% CI 0.50-0.83) and a p-value of 0.0005 are displayed, indicating statistical analysis results.*
FDA Label Image

Figure_2 (Figure 2)

Figure_2 (Figure 2)
A cumulative hazard curve comparing placebo and Atorvastatin over a follow-up period of up to five years. The y-axis represents cumulative hazard percentage, and the x-axis shows time to first primary endpoint in years. The Atorvastatin group shows a lower cumulative hazard compared to placebo throughout the period, with a hazard ratio (HR) of 0.63 (0.48-0.83) and a p-value of 0.001.*
FDA Label Image

Figure_3 (Figure 3)

Figure_3 (Figure 3)
A line graph comparing the percentage of subjects experiencing the first major cardiovascular event over time in years for Atorvastatin 10 mg and 80 mg dosages. The x-axis represents time up to 5 years, and the y-axis shows the percentage of subjects experiencing the event. The graph includes a hazard ratio (HR) of 0.78 with confidence intervals and a p-value indicating statistical significance.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of the active ingredient atorvastatin calcium, shown with calcium and water molecules indicating its hydrated form.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.